Cookie Consent

Our website uses cookies to provide your browsing experience and relavent informations.Before continuing to use our website, you agree & accept of our Cookie Policy & Privacy Policy

Abbott India rises as Q1 PAT jumps 12% YoY to Rs 366 cr
(12 Aug 2025, 13:50)

Profit before tax (PBT) stood at Rs 493.13 crore in Q1 FY26, up 12.78% year on year (YoY).

Total expenses increased 10.97% to Rs 1,318.06 crore in Q1 FY26 as against Rs 1,187.72 crore posted in same quarter last year. The cost of materials consumed stood at Rs 146.18 crore (down 0.06% YoY), employee benefit expense was at Rs 168.01 crore (up 4.31% YoY) and finance cost was at Rs 5.82 crore (up 111.63% YoY) during the period under review.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Powered by Capital Market - Live News

Barjeel Geojit Financial Services L.L.C
# Plan your financial goals with us
@2018 Barjeel Geojit Financial Services L.L.C    All Rights Reserved
Designed, Developed and Powered by CMOTS Infotech (ISO 9001:2015 Certified)